Document is current
Any future updates will be listed below
-
Authors
Kany, Shinwan
Rämö, Joel T. https://orcid.org/0000-0002-6429-5149
Hou, Cody
Jurgens, Sean J. https://orcid.org/0000-0002-1605-9782
Khurshid, Shaan
Nauffal, Victor https://orcid.org/0000-0001-7199-299X
Cunningham, Jonathan W.
Lau, Emily S.
Koyama, Satoshi https://orcid.org/0000-0002-9286-0360
,
Ho, Jennifer E. https://orcid.org/0000-0002-7987-4768
Olgin, Jeffrey E.
Elmariah, Sammy
Palotie, Aarno
Lindsay, Mark E. https://orcid.org/0000-0001-6724-7938
Ellinor, Patrick T. https://orcid.org/0000-0002-2067-0533
Pirruccello, James P. https://orcid.org/0000-0001-6088-4037
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K08HL159346)
- License Information
-
More Information
Article History
Received: 19 August 2023
Accepted: 7 October 2025
First Online: 19 December 2025
Competing interests
: J.E.H. has received past research support from Bayer AG focused on machine learning and cardiovascular disease. E.S.L. has received previous honoraria and consulting fees from Roche Diagnostics and Astellas Pharma. S. Khurshid receives sponsored research support from Bayer AG. S.E. is supported by a grant from Edwards Lifesciences, Abbott Vascular and Medtronic; has received consulting fees from Edwards Lifesciences and holds equity in Prospect Health. P.T.E. is supported by a grant from Bayer AG to the Broad Institute focused on the genetics and therapeutics of cardiovascular diseases and has also served on advisory boards or consulted for Bayer AG, Quest Diagnostics, MyoKardia and Novartis. The other authors declare no competing interests.
